Literature DB >> 12271376

Optic disc drusen, angioid streaks, and mottled fundus in various combinations in a Sicilian family.

Salvatore Li Volti1, Teresio Avitabile, Giovanni Li Volti, Ilaria Meloni, Paola Forabosco, Filippo Marano, Sebastiano Bianca, Alessandra Renieri.   

Abstract

BACKGROUND: We describe a Sicilian family in which optic disc drusen, angioid streaks, and mottled fundus--without dermatological signs of pseudoxanthoma elasticum (PXE)--are present in various combinations and segregate as an autosomal dominant trait. Since these ocular manifestations can be part of the clinical signs of PXE, we examined the possible involvement of a mutation in the ABCC6 gene, which is known to be responsible for PXE.
METHODS: Linkage analysis was performed with both intragenic and flanking markers. We used marker D16B9722 and a single-nucleotide polymorphism located in exon 15 of the ABCC6 gene. LOD score values were calculated on the assumption of a gene frequency of 0.0001 and both complete penetrance and reduced penetrance (90%), with theta values between 0.0 and 0.4.
RESULTS: LOD score values excluded the involvement of the ABCC6 gene.
CONCLUSIONS: The dominant transmission of optic disc drusen, mottled fundus, and angioid streaks in this family is not due to alterations in the ABCC6 gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12271376     DOI: 10.1007/s00417-002-0534-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  3 in total

1.  Angioid streaks in identical twins.

Authors:  D Kumudhan; E J Wallace; S T D Roxburgh
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

Review 2.  Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.

Authors:  N Chassaing; L Martin; P Calvas; M Le Bert; A Hovnanian
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

Review 3.  Optic disk drusen in children.

Authors:  Melinda Y Chang; Stacy L Pineles
Journal:  Surv Ophthalmol       Date:  2016-03-29       Impact factor: 6.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.